Personal tools

MCL coexpression mm9:1599: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002193!2.46e-19!48;UBERON:0002405!2.46e-19!48;UBERON:0002390!2.71e-18!45;UBERON:0003061!2.71e-18!45;UBERON:0003081!2.10e-11!87;UBERON:0002371!2.66e-10!16;UBERON:0004177!2.77e-09!29;UBERON:0005057!2.77e-09!29;UBERON:0001474!8.43e-09!22;UBERON:0004765!8.43e-09!22;UBERON:0001434!8.43e-09!22;UBERON:0000077!2.79e-08!35;UBERON:0002384!4.21e-08!46;UBERON:0001041!8.52e-08!80;UBERON:0000926!9.05e-08!120;UBERON:0004120!9.05e-08!120;UBERON:0006603!9.05e-08!120;UBERON:0001004!3.13e-07!42;UBERON:0002204!3.97e-07!32;UBERON:0003408!4.85e-07!24;UBERON:0000065!5.88e-07!41;UBERON:0006562!8.96e-07!24;UBERON:0001557!8.96e-07!24;UBERON:0001042!8.96e-07!24;UBERON:0008814!8.96e-07!24;UBERON:0009145!8.96e-07!24;UBERON:0002370!9.38e-07!23;UBERON:0000974!9.38e-07!23;UBERON:0004807!9.38e-07!23;UBERON:0005058!9.38e-07!23;UBERON:0003351!9.38e-07!23;UBERON:0009113!9.38e-07!23;UBERON:0003295!9.38e-07!23;UBERON:0009722!9.38e-07!23;UBERON:0005562!9.38e-07!23;UBERON:0007690!9.38e-07!23
|ontology_enrichment_uberon=UBERON:0002193!2.46e-19!48;UBERON:0002405!2.46e-19!48;UBERON:0002390!2.71e-18!45;UBERON:0003061!2.71e-18!45;UBERON:0003081!2.10e-11!87;UBERON:0002371!2.66e-10!16;UBERON:0004177!2.77e-09!29;UBERON:0005057!2.77e-09!29;UBERON:0001474!8.43e-09!22;UBERON:0004765!8.43e-09!22;UBERON:0001434!8.43e-09!22;UBERON:0000077!2.79e-08!35;UBERON:0002384!4.21e-08!46;UBERON:0001041!8.52e-08!80;UBERON:0000926!9.05e-08!120;UBERON:0004120!9.05e-08!120;UBERON:0006603!9.05e-08!120;UBERON:0001004!3.13e-07!42;UBERON:0002204!3.97e-07!32;UBERON:0003408!4.85e-07!24;UBERON:0000065!5.88e-07!41;UBERON:0006562!8.96e-07!24;UBERON:0001557!8.96e-07!24;UBERON:0001042!8.96e-07!24;UBERON:0008814!8.96e-07!24;UBERON:0009145!8.96e-07!24;UBERON:0002370!9.38e-07!23;UBERON:0000974!9.38e-07!23;UBERON:0004807!9.38e-07!23;UBERON:0005058!9.38e-07!23;UBERON:0003351!9.38e-07!23;UBERON:0009113!9.38e-07!23;UBERON:0003295!9.38e-07!23;UBERON:0009722!9.38e-07!23;UBERON:0005562!9.38e-07!23;UBERON:0007690!9.38e-07!23
|tfbs_overrepresentation_for_novel_motifs=0.557864,0.612204,0.529553,0.603273,0.406364,0.618805,0.715644,0.812379,0.310789,0.370407,0.668936,0.702872,0.300533,0.728641,1.0876,0,0.930881,0.397593,0.775038,0.545768,0.489529,0.874994,0.727684,0.404661,0.537749,0.757752,0.754069,0.641282,0.456327,0.227599,0.626183,1.03545,0.395107,0.704734,0.425309,0.20704,0.384813,0.699032,0.360612,0.876199,0.401916,0.631725,0.419293,0.426986,0.84962,0.591277,0.847828,0.658142,0.370501,0.459555,0.912738,0.786094,0.220111,1.18062,1.19842,0.73621,0.469329,0.689304,1.34464,0.734051,1.01481,0.796017,0.323911,0.901018,0.747985,0.943088,1.33705,1.68977,1.00999,1.54147,0.509047,0.30684,0.46305,1.23259,0.714607,0.686172,0.253065,0.835925,0.997094,0.494135,0.308173,0.948899,0.794502,0.293164,1.1148,0.272382,0.0882907,0.227755,0.852952,1.85284,1.40768,1.11989,1.04863,0.412897,0.356133,0.3366,0.806207,1.05152,0.848095,0.590368,0.384901,1.03517,1.16282,0.913356,0.91226,0.631253,0.97421,0.653843,0.499439,0.491483,0.550229,1.16464,0.495367,0.674448,1.41481,0.399936,2.24107,0.607321,0.932233,0.380707,1.23809,0.879184,0.759676,0.834976,1.46955,1.00091,0.724289,1.04166,1.33551,0.416189,1.14546,0.595426,1.3055,0.750642,1.43666,0.44142,0.566955,0.633235,1.3869,2.2222,1.82084,1.34183,0.772375,1.04623,0.905521,0.632211,0.851091,2.18247,0.569503,0.408309,0.230371,0.826123,1.18223,0.343194,0.749664,1.26545,0.787153,0.438007,0.555203,0.566652,1.39653,1.11392,1.00137,1.35103,0.90208,0.741834,0.383572,0.701187,0.425122
}}
}}

Revision as of 20:09, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr11:95703597..95703621,+p1@Gngt2
Mm9::chr14:70575113..70575136,-p7@Pdlim2
Mm9::chr16:32165540..32165580,-p1@Lrrc33
Mm9::chr17:50329738..50329814,-p1@Rftn1
Mm9::chr5:128097742..128097796,-p1@Slc15a4


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
hemolymphoid system2.46e-1948
immune system2.46e-1948
hematopoietic system2.71e-1845
blood island2.71e-1845
lateral plate mesoderm2.10e-1187
bone marrow2.66e-1016
hemopoietic organ2.77e-0929
immune organ2.77e-0929
bone element8.43e-0922
skeletal element8.43e-0922
skeletal system8.43e-0922
mixed endoderm/mesoderm-derived structure2.79e-0835
connective tissue4.21e-0846
foregut8.52e-0880
mesoderm9.05e-08120
mesoderm-derived structure9.05e-08120
presumptive mesoderm9.05e-08120
respiratory system3.13e-0742
musculoskeletal system3.97e-0732
gland of gut4.85e-0724
respiratory tract5.88e-0741
pharynx8.96e-0724
upper respiratory tract8.96e-0724
chordate pharynx8.96e-0724
pharyngeal arch system8.96e-0724
pharyngeal region of foregut8.96e-0724
thymus9.38e-0723
neck9.38e-0723
respiratory system epithelium9.38e-0723
hemolymphoid system gland9.38e-0723
pharyngeal epithelium9.38e-0723
thymic region9.38e-0723
pharyngeal gland9.38e-0723
entire pharyngeal arch endoderm9.38e-0723
thymus primordium9.38e-0723
early pharyngeal endoderm9.38e-0723


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}